ES2421915T3 - Derivados de amida del ácido hialurónico en osteoartrosis - Google Patents

Derivados de amida del ácido hialurónico en osteoartrosis

Info

Publication number
ES2421915T3
ES2421915T3 ES06707203T ES06707203T ES2421915T3 ES 2421915 T3 ES2421915 T3 ES 2421915T3 ES 06707203 T ES06707203 T ES 06707203T ES 06707203 T ES06707203 T ES 06707203T ES 2421915 T3 ES2421915 T3 ES 2421915T3
Authority
ES
Spain
Prior art keywords
hyaluronic acid
osteoarthritis
acid amide
amide derivatives
hexadecylamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06707203T
Other languages
English (en)
Inventor
Antonella Schiavinato
Davide Bellini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici SpA filed Critical Fidia Farmaceutici SpA
Application granted granted Critical
Publication of ES2421915T3 publication Critical patent/ES2421915T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Hexadecilamidas de ácido hialurónico caracterizadas porque la hexadecilamida del ácido hialurónico tiene ungrado de amidación entre 0.1 y 5% para usar en el tratamiento de articulaciones afectadas por osteoartrosis,trauma, inflamación y/o desgaste debido al envejecimiento de la estructura de la articulación.
ES06707203T 2005-03-02 2006-02-20 Derivados de amida del ácido hialurónico en osteoartrosis Expired - Lifetime ES2421915T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000056A ITPD20050056A1 (it) 2005-03-02 2005-03-02 Derivati ammidici del'acido ialuronico in osteoartrosi
PCT/EP2006/001644 WO2006092233A1 (en) 2005-03-02 2006-02-20 Amide derivatives of hyaluronic acid in osteoarthrosis

Publications (1)

Publication Number Publication Date
ES2421915T3 true ES2421915T3 (es) 2013-09-06

Family

ID=36582056

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06707203T Expired - Lifetime ES2421915T3 (es) 2005-03-02 2006-02-20 Derivados de amida del ácido hialurónico en osteoartrosis

Country Status (14)

Country Link
US (1) US7863256B2 (es)
EP (2) EP1853279B1 (es)
JP (1) JP5047814B2 (es)
AU (1) AU2006220034B2 (es)
CA (1) CA2598331C (es)
CY (1) CY1115215T1 (es)
DK (1) DK1853279T3 (es)
ES (1) ES2421915T3 (es)
IL (1) IL185248A0 (es)
IT (1) ITPD20050056A1 (es)
PL (1) PL1853279T3 (es)
PT (1) PT1853279E (es)
SI (1) SI1853279T1 (es)
WO (1) WO2006092233A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2360188B1 (en) * 2008-11-05 2014-09-17 National University Corporation Tokyo Medical and Dental University Hyaluronic acid derivative and pharmaceutical composition thereof
RU2409664C1 (ru) * 2009-04-29 2011-01-20 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ получения жизнеспособных клеток молочной железы
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
IT1395392B1 (it) 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITPD20120173A1 (it) * 2012-05-31 2013-12-01 Fidia Farmaceutici "nuovo sistema di rilascio di proteine idrofobiche"
PL2900247T3 (pl) * 2012-09-26 2018-05-30 Bone Therapeutics S.A. Kompozycje zawierające osocze poddane obróbce rozpuszczalnikiem/detergentem i kwas hialuronowy do zastosowania w leczeniu zaburzeń układu mięśniowo-szkieletowego
EP4137139A1 (en) 2013-07-10 2023-02-22 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
ES2871199T3 (es) 2015-09-24 2021-10-28 Matrix Biology Inst Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas
RU2621269C1 (ru) * 2016-04-27 2017-06-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Чеченский государственный университет" Способ деалгезии при гонартрозе
IT201700110784A1 (it) * 2017-10-03 2019-04-03 Fidia Farm Spa Composizioni farmaceutiche contenenti Acido Ialuronico e Carnosina e relativo uso
IT201900006038A1 (it) 2019-04-18 2020-10-18 Fidia Farm Spa Composizioni farmaceutiche comprendenti statine e derivati dell’acido ialuronico
IT201900009933A1 (it) * 2019-06-24 2020-12-24 Fidia Farm Spa Composizioni farmaceutiche comprendenti derivati ammidici dell'acido ialuronico per uso nel trattamento di traumi ossei, in particolare in pazienti con problemi di osteopenia o osteoporosi
IT202000005692A1 (it) 2020-03-17 2021-09-17 Fidia Farm Spa Bio-inchiostro per stampa 3D, relativo coniugato e processo di preparazione di un intermedio costituito da un linker fotoreattivo

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55161801A (en) 1979-06-06 1980-12-16 Seikagaku Kogyo Co Ltd Fluorescence-labeled acid mucopolysaccharide and preparation thereof
IN163192B (es) 1983-10-11 1988-08-20 Fidia Spa
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4937270A (en) 1987-09-18 1990-06-26 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IT1217458B (it) 1988-05-02 1990-03-22 Crinos Ind Farmacoriologica S Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
JPH0755961B2 (ja) 1989-04-18 1995-06-14 工業技術院長 新規なヒアルロン酸誘導体及びその製造方法
EP0416250A3 (en) 1989-08-01 1991-08-28 The Research Foundation Of State University Of New York N-acylurea and o-acylisourea derivatives of hyaluronic acid
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
CA2070672C (en) 1990-10-18 2002-10-08 Kazuo Akima Compound of medicinal ingredient and hyaluronic acid and process for producing the same
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
US5612360A (en) 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
IT1260154B (it) * 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
JP3209457B2 (ja) 1992-12-11 2001-09-17 本田技研工業株式会社 バッテリの残容量検出方法
IT1263316B (it) * 1993-02-12 1996-08-05 Fidia Advanced Biopolymers Srl Tessuto non tessuto multistrato in cui uno degli strati e' costituito essenzialmente da esteri dell'acido ialuronico
IT1268955B1 (it) 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Esteri attivi di polisaccaridi carbossilici
CA2162957C (en) 1994-11-17 2011-08-02 Michinori Waki Cinnamic acid derivative
IT1281876B1 (it) 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci.
JP4018181B2 (ja) 1995-11-07 2007-12-05 生化学工業株式会社 グリコサミノグリカン誘導体およびその製造法
JP3925955B2 (ja) 1996-04-26 2007-06-06 株式会社クラレ 癒着防止材
US5657582A (en) * 1996-06-21 1997-08-19 Chitwood; Mark L. Rain gutter downspout noise attenuation apparatus
JP3955652B2 (ja) 1996-10-15 2007-08-08 株式会社ネーテック 合成アミノ糖類誘導体及びその製造方法
JPH10298164A (ja) 1997-02-27 1998-11-10 Tanabe Seiyaku Co Ltd イソキノリノン誘導体、その製法及びその合成中間体
ATE229038T1 (de) * 1997-04-04 2002-12-15 Fidia Advanced Biopolymers Srl N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
JP3410476B2 (ja) 1997-04-18 2003-05-26 大鵬薬品工業株式会社 新規なエポキシコハク酸アミド誘導体又はその塩
GB9710990D0 (en) 1997-05-28 1997-07-23 Danisco Modification process
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
KR20040009891A (ko) 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법

Also Published As

Publication number Publication date
SI1853279T1 (sl) 2013-08-30
JP2008531148A (ja) 2008-08-14
US20080069884A1 (en) 2008-03-20
JP5047814B2 (ja) 2012-10-10
HK1106161A1 (en) 2008-03-07
CA2598331C (en) 2013-07-30
PT1853279E (pt) 2013-07-18
ITPD20050056A1 (it) 2006-09-03
US7863256B2 (en) 2011-01-04
IL185248A0 (en) 2008-06-05
CA2598331A1 (en) 2006-09-08
EP1853279B1 (en) 2013-05-01
AU2006220034A1 (en) 2006-09-08
WO2006092233A1 (en) 2006-09-08
EP1853279A1 (en) 2007-11-14
DK1853279T3 (da) 2013-07-15
CY1115215T1 (el) 2017-01-04
PL1853279T3 (pl) 2013-09-30
EP2457574A1 (en) 2012-05-30
AU2006220034B2 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
BR112014007675A2 (pt) tratamento de doença articular degenerativa
PA8811501A1 (es) Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
MX2009001327A (es) Compuestos de indol.
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
JO3469B1 (ar) طافرات fgf21 واستخداماتها
CO6362020A2 (es) Mutantes fgf21 y uso de los mismos
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
EP2381957A4 (en) THERAPEUTIC MODULATION OF VAGINAL ELEMENTAL BODY HUMIDIFICATION
CL2008002692A1 (es) Uso de una composicion a base de bayas de goji o una parte de la misma para preparar un producto util para tratar o prevenir la inflamacion.
CL2018001420A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853)
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης
PL1940381T3 (pl) Farmaceutyczne kompozycje do oczu oparte na aminokwasach i hialuronianie sodu
CY1115215T1 (el) Παραγωγα αμιδιου υαλουρονικου οξεος στην εκφυλιστικη οστεοαρθροπαθεια
EA201270361A1 (ru) Птеридины и их применение в качестве агрохимикатов
CL2009000727A1 (es) Compuestos derivados de n-hidroxi-3-fenilprop-2-enemida y n-hidroxi-3-fenilpropanamida sustituidos; inhibidores de la enzima desacetilasa; su composicion farmaceutica; utiles en el tratamiento del cancer, tumores, psoriasis, alzheimer, entre otras.
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
EA200970981A1 (ru) Пептидная смесь в качестве стабилизатора вина
CL2008002384A1 (es) Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
WO2020128070A3 (de) Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BR112012015449A2 (pt) suspensão de monoidrato de calcipotriol, monoidrato de calcipotriol, processo para preparar nanocristais de monoidrato de calcipotriol, e, composição farmacêutica